vs

Side-by-side financial comparison of Inspire Medical Systems, Inc. (INSP) and PRA GROUP INC (PRAA). Click either name above to swap in a different company.

PRA GROUP INC is the larger business by last-quarter revenue ($333.4M vs $204.6M, roughly 1.6× Inspire Medical Systems, Inc.). On growth, PRA GROUP INC posted the faster year-over-year revenue change (13.7% vs 1.6%). Over the past eight quarters, PRA GROUP INC's revenue compounded faster (14.2% CAGR vs 2.2%).

Inspire Medical Systems, Inc. is a medical technology firm that develops, manufactures and commercializes implantable neurostimulation solutions for obstructive sleep apnea. Its core product serves patients intolerant to CPAP therapy, with main markets across North America, Europe, and select Asia-Pacific regions, operating in sleep medicine and otolaryngology segments.

PRA Group, Inc. is a publicly traded debt buyer and debt collection company based in Norfolk, Virginia. The company buys delinquent consumer debt from credit card issuers and other financial institutions at a discount and pursues collection of the full debt owed. Founded in 1996, PRA Group employs more than 3200 people in 18 countries.

INSP vs PRAA — Head-to-Head

Bigger by revenue
PRAA
PRAA
1.6× larger
PRAA
$333.4M
$204.6M
INSP
Growing faster (revenue YoY)
PRAA
PRAA
+12.1% gap
PRAA
13.7%
1.6%
INSP
Faster 2-yr revenue CAGR
PRAA
PRAA
Annualised
PRAA
14.2%
2.2%
INSP

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
INSP
INSP
PRAA
PRAA
Revenue
$204.6M
$333.4M
Net Profit
$56.5M
Gross Margin
86.5%
Operating Margin
13.0%
37.7%
Net Margin
17.0%
Revenue YoY
1.6%
13.7%
Net Profit YoY
206.3%
EPS (diluted)
$-0.39
$1.47

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
INSP
INSP
PRAA
PRAA
Q1 26
$204.6M
Q4 25
$269.1M
$333.4M
Q3 25
$224.5M
$311.1M
Q2 25
$217.1M
$287.7M
Q1 25
$201.3M
$269.6M
Q4 24
$239.7M
$293.2M
Q3 24
$203.2M
$281.5M
Q2 24
$195.9M
$284.2M
Net Profit
INSP
INSP
PRAA
PRAA
Q1 26
Q4 25
$136.1M
$56.5M
Q3 25
$9.9M
$-407.7M
Q2 25
$-3.6M
$42.4M
Q1 25
$3.0M
$3.7M
Q4 24
$35.2M
$18.5M
Q3 24
$18.5M
$27.2M
Q2 24
$9.8M
$21.5M
Gross Margin
INSP
INSP
PRAA
PRAA
Q1 26
86.5%
Q4 25
86.6%
Q3 25
85.8%
Q2 25
84.0%
Q1 25
84.7%
Q4 24
85.0%
Q3 24
84.1%
Q2 24
84.8%
Operating Margin
INSP
INSP
PRAA
PRAA
Q1 26
13.0%
Q4 25
17.1%
37.7%
Q3 25
4.3%
-101.4%
Q2 25
-1.5%
29.6%
Q1 25
-0.7%
27.7%
Q4 24
13.3%
32.1%
Q3 24
7.0%
32.0%
Q2 24
2.6%
31.4%
Net Margin
INSP
INSP
PRAA
PRAA
Q1 26
Q4 25
50.6%
17.0%
Q3 25
4.4%
-131.0%
Q2 25
-1.7%
14.7%
Q1 25
1.5%
1.4%
Q4 24
14.7%
6.3%
Q3 24
9.1%
9.6%
Q2 24
5.0%
7.6%
EPS (diluted)
INSP
INSP
PRAA
PRAA
Q1 26
$-0.39
Q4 25
$4.57
$1.47
Q3 25
$0.34
$-10.43
Q2 25
$-0.12
$1.08
Q1 25
$0.10
$0.09
Q4 24
$1.17
$0.47
Q3 24
$0.60
$0.69
Q2 24
$0.32
$0.54

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
INSP
INSP
PRAA
PRAA
Cash + ST InvestmentsLiquidity on hand
$98.9M
$104.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$792.3M
$979.9M
Total Assets
$911.4M
$5.1B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
INSP
INSP
PRAA
PRAA
Q1 26
$98.9M
Q4 25
$308.3M
$104.4M
Q3 25
$322.6M
$107.5M
Q2 25
$300.9M
$131.6M
Q1 25
$369.2M
$128.7M
Q4 24
$445.5M
$105.9M
Q3 24
$411.0M
$141.1M
Q2 24
$439.7M
$118.9M
Stockholders' Equity
INSP
INSP
PRAA
PRAA
Q1 26
$792.3M
Q4 25
$781.2M
$979.9M
Q3 25
$666.5M
$928.5M
Q2 25
$677.8M
$1.3B
Q1 25
$635.7M
$1.2B
Q4 24
$689.7M
$1.1B
Q3 24
$696.6M
$1.2B
Q2 24
$638.1M
$1.1B
Total Assets
INSP
INSP
PRAA
PRAA
Q1 26
$911.4M
Q4 25
$907.3M
$5.1B
Q3 25
$807.7M
$5.0B
Q2 25
$802.2M
$5.4B
Q1 25
$730.8M
$5.1B
Q4 24
$808.4M
$4.9B
Q3 24
$796.2M
$4.9B
Q2 24
$728.4M
$4.7B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
INSP
INSP
PRAA
PRAA
Operating Cash FlowLast quarter
$-85.5M
Free Cash FlowOCF − Capex
$-90.4M
FCF MarginFCF / Revenue
-27.1%
Capex IntensityCapex / Revenue
1.4%
Cash ConversionOCF / Net Profit
-1.51×
TTM Free Cash FlowTrailing 4 quarters
$-169.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
INSP
INSP
PRAA
PRAA
Q1 26
Q4 25
$52.5M
$-85.5M
Q3 25
$68.5M
$-10.1M
Q2 25
$2.7M
$-12.9M
Q1 25
$-6.7M
$-52.6M
Q4 24
$69.2M
$-94.6M
Q3 24
$52.3M
$-35.0M
Q2 24
$-78.0K
$-29.5M
Free Cash Flow
INSP
INSP
PRAA
PRAA
Q1 26
Q4 25
$41.8M
$-90.4M
Q3 25
$58.1M
$-11.3M
Q2 25
$-6.3M
$-14.2M
Q1 25
$-15.1M
$-53.5M
Q4 24
$62.2M
$-98.6M
Q3 24
$44.3M
$-36.1M
Q2 24
$-12.5M
$-30.8M
FCF Margin
INSP
INSP
PRAA
PRAA
Q1 26
Q4 25
15.5%
-27.1%
Q3 25
25.9%
-3.6%
Q2 25
-2.9%
-4.9%
Q1 25
-7.5%
-19.8%
Q4 24
25.9%
-33.6%
Q3 24
21.8%
-12.8%
Q2 24
-6.4%
-10.8%
Capex Intensity
INSP
INSP
PRAA
PRAA
Q1 26
Q4 25
4.0%
1.4%
Q3 25
4.6%
0.4%
Q2 25
4.1%
0.4%
Q1 25
4.2%
0.3%
Q4 24
2.9%
1.4%
Q3 24
3.9%
0.4%
Q2 24
6.3%
0.5%
Cash Conversion
INSP
INSP
PRAA
PRAA
Q1 26
Q4 25
0.39×
-1.51×
Q3 25
6.90×
Q2 25
-0.30×
Q1 25
-2.24×
-14.37×
Q4 24
1.96×
-5.13×
Q3 24
2.83×
-1.29×
Q2 24
-0.01×
-1.37×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

INSP
INSP

Segment breakdown not available.

PRAA
PRAA

GB$170.1M51%
Other$163.3M49%

Related Comparisons